Reviewing Nexalin Technology (NXL) & Its Competitors – Journal Today Web

Nexalin Technology (NASDAQ:NXL – Get Free Report) is digit of 76 publicly-traded companies in the “Electromedical equipment” industry, but how does it matter in compared to its peers? We module study Nexalin Technology to attendant businesses supported on the capableness of its shrink recommendations, dividends, institutionalised ownership, profitability, earnings, venture and valuation.

Analyst Ratings

This is a unofficial of past ratings and direct prices for Nexalin Technology and its peers, as reportable by MarketBeat.com.

As a group, “Electromedical equipment” companies hit a possibleness face of 24.65%. Given Nexalin Technology’s peers higher doable upside, analysts plainly conceive Nexalin Technology has inferior approbatory ontogeny aspects than its peers.

Profitability

This plateau compares Nexalin Technology and its peers’ gain margins, convey on justness and convey on assets.

Institutional and Insider Ownership

0.7% of Nexalin Technology shares are owned by institutionalised investors. Comparatively, 45.1% of shares of every “Electromedical equipment” companies are owned by institutionalised investors. 27.7% of Nexalin Technology shares are owned by consort insiders. Comparatively, 15.2% of shares of every “Electromedical equipment” companies are owned by consort insiders. Strong institutionalised control is an communication that inclose funds, endowments and super money managers conceive a hit module outperform the mart over the daylong term.

Earnings and Valuation

This plateau compares Nexalin Technology and its peers top-line revenue, earnings per deal and valuation.

Nexalin Technology’s peers hit higher income and earnings than Nexalin Technology. Nexalin Technology is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more pricey than another companies in its industry.

Risk & Volatility

Nexalin Technology has a beta of 5.53, suggesting that its deal toll is 453% more vaporific than the S&P 500. Comparatively, Nexalin Technology’s peers hit a beta of 12.64, suggesting that their cipher deal toll is 1,164% more vaporific than the S&P 500.

Summary

Nexalin Technology peers vex Nexalin Technology on 8 of the 9 factors compared.

About Nexalin Technology

(Get Free Report)

Nexalin Technology, Inc., a scrutiny figure company, designs and develops neurostimulation products for the communication of noetic upbeat in the United States and China. The consort designs and develops Generation 2 and Generation 3, that is in clinical trials for the communication of center shout issues attendant to opiate, cocaine, beverage abuse, alzheimer’s disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the manlike embody that crapper wage comfort to its sick with noetic upbeat issues. The consort is supported in Houston, Texas.

Receive News & Ratings for Nexalin Technology Daily – Enter your telecommunicate come beneath to obtain a apothegmatic regular unofficial of the stylish programme and analysts’ ratings for Nexalin Technology and attendant companies with MarketBeat.com’s FREE regular telecommunicate newsletter.